Related by context. All words. (Click for frequent words.) 81 Unstable Angina Non 76 Infarction 76 Patients Undergoing 76 Pulmonary Arterial Hypertension 75 Elderly Patients 75 Heart Failure Patients 75 Oral Fingolimod 75 Hormone Receptor Positive 75 Improves Outcomes 75 Renal Impairment 75 Advanced Melanoma 75 Less Invasive 74 Relapsing Multiple Sclerosis 74 Meets Primary Endpoint 74 Inhaled Nitric Oxide 74 ST Segment Elevation 74 Carotid Stenting 74 Metastatic Prostate Cancer 74 Minimally Invasive Treatment 74 Treated Patients 74 ORLive Presents 74 Increased Mortality 74 Resistant Hypertension 74 Study Evaluating 74 Ischemic Stroke 74 Unresectable 74 Knee Osteoarthritis 73 Adjuvant Chemotherapy 73 Previously Untreated 73 Investigational Treatment 73 Overactive Bladder 73 Intracranial Aneurysms 73 Spinal Fractures 73 Unfractionated Heparin 73 Pooled Analysis 73 REMINDER ORLive Presents 73 Improve Survival 73 Advanced Prostate Cancer 73 Combination Treatment 73 Bone Metastases 73 First Patient Treated 73 Acute Heart Failure 73 Renal Cell Carcinoma 73 Pediatric Patients 73 Successfully Treated 73 Secondary Hyperparathyroidism 73 Newly Diagnosed Multiple Myeloma 73 Advanced Colorectal Cancer 73 Mitral Regurgitation 73 Chronic Hepatitis C 73 Chronic Sinusitis 73 Rheumatoid Arthritis Patients 72 Is Well Tolerated 72 Improves Survival 72 Clinical Trial Evaluating 72 Valvular Heart Disease 72 Catheter Ablation 72 Artery Disease 72 Myeloma Patients 72 Endovascular Treatment 72 Peripheral Arterial 72 Ventricular Arrhythmias 72 Minimally Invasive Procedure 72 Relapsed Multiple Myeloma 72 Acute Ischemic Stroke 72 Unstable Angina 72 Relapsing Remitting Multiple Sclerosis 72 Phase 2b Clinical Trial 72 Study Showed 72 Metastatic Renal Cell Carcinoma 72 Survival Benefit 72 Prospective Randomized 72 NAVISTAR R 72 Premenopausal Women 72 Prolongs Survival 72 Treatment Naive Patients 72 Acute Coronary Syndromes 72 First Patient Enrolled 72 Neoadjuvant Chemotherapy 72 Drug Prevents 72 Critically Ill Patients 72 Obese Patients 72 Genes Predict 71 Venous Thromboembolism 71 Breast Cancer Recurrence 71 Patients Treated 71 Acute Myocardial Infarction 71 Hemolysis 71 Urinary Incontinence 71 Complicated Skin 71 Aortic Valve Replacement 71 Patients Receiving 71 Sinus Infections 71 Liver Metastases 71 Adjunctive Therapy 71 Previously Treated 71 Bare Metal Stents 71 Localized Prostate Cancer 71 Hyperlipidemia 71 Plaque Psoriasis 71 Osteoarthritis Patients 71 Treatment Regimen 71 Image Guided 71 Statin Therapy 71 Appears Safe 71 Pulmonary Artery 71 Adjunctive 71 Myelodysplastic Syndromes 71 Kidney Transplant Patients 71 Multicenter Trial 71 Reduces Mortality 71 Treatment Resistant 71 Soft Tissue Sarcoma 71 Patients Suffering 71 Severe Asthma 71 Patients Treated With 71 Patient Outcomes 71 Implantable Device 71 Prostate Cancer Patients 71 Severe Sepsis 71 Improved Survival 71 Serious Infections 71 Castration Resistant Prostate Cancer 71 Chronic Bronchitis 71 Bloodstream Infections 71 Phase 2b Trial 71 Heart Transplant Recipients 71 Immunomedics Announces 70 Fungal Infections 70 Lung Injury 70 Septic Shock 70 Patient Enrollment 70 Postmenopausal Osteoporosis 70 Fracture Risk 70 Diabetic Neuropathic Pain 70 Hyperkalemia 70 Diabetic Patients 70 Radiofrequency Ablation 70 Hip Fractures 70 Post Operative 70 myocardial infarction ventricular fibrillation 70 Proven Effective 70 Brain Metastases 70 Endologix Powerlink System 70 Metastatic Colorectal Cancer 70 Inhaled Corticosteroids 70 Treatment Reduces 70 Cardiac Resynchronization 70 Hormone Refractory Prostate Cancer 70 Newly Diagnosed Breast Cancer 70 Androgen Deprivation Therapy 70 Versus Placebo 70 Diabetic Foot Ulcers 70 See CLINICAL PHARMACOLOGY 70 Demonstrates Positive 70 Total Knee Arthroplasty 70 Glycemic Control 70 Prophylactic Treatment 70 Abciximab 70 Surgical Procedures 70 Successfully Treats 70 Adjuvant Therapy 70 Blood Clots 70 Randomized Trials 70 Clinical Trial Results 70 Cardiovascular Outcomes 70 Renal Anemia 70 Nebulized 70 Long Term Efficacy 70 Significantly Reduced 70 Postmenopausal Women 70 Sustained Reduction 70 Experimental Vaccine 70 Acute Myocardial 70 Treating Chronic 70 Ischemic 70 Single Dose 70 Partial Onset Seizures 70 Reperfusion Injury 70 Mg Usa 70 Severe Acne 70 CT Angiography 70 Chronic HCV 70 Myocardial Ischemia 70 Left Ventricular 70 Cardiovascular Events 70 Vascular Grafts 70 J Shoulder Elbow 70 ACE Inhibitors 70 Chronic Hepatitis B 70 Treatment Shows Promise 70 Dual Antiplatelet Therapy 70 Hospital Acquired Pneumonia 70 Advanced Renal Cell 70 Phase IIb Trial 70 Kidney Tumors 69 Well Tolerated 69 endoluminal stent graft 69 Demonstrates Sustained 69 Naive Patients 69 Shows Promise Against 69 Contrast Agent 69 Intravascular 69 Non Alcoholic Fatty 69 Metastatic Melanoma 69 Investigational Drug 69 Abdominal Pain 69 Lupus Nephritis 69 Subgroup Analysis 69 Diabetic Neuropathy 69 Chronic Heart Failure 69 Study Shows Promise 69 Slow Progression 69 Complete Remission 69 J Am Coll 69 Vertebral Fractures 69 Antitumor Activity 69 Hernia Repair 69 FDA Approvals 69 Spinal Manipulation 69 Benign Prostatic Hyperplasia 69 Am J Respir 69 Bipolar Depression 69 Diabetic Foot Ulcer 69 aneurysms AAA 69 Occlusive Disease 69 Vasomotor Symptoms 69 Myelodysplastic Syndrome 69 Critical Limb Ischemia CLI 69 Sleep Disturbances 69 Coronary Angiography 69 Guidelines Issued 69 Robotic Assisted 69 Preclinical Data 69 Recurrent Ovarian Cancer 69 Secca System 69 Renal Function 69 Liver Transplants 69 Lung Tumors 69 Randomized Clinical Trial 69 Left Ventricular Hypertrophy 69 Vertebral Compression Fractures 69 Completes Enrollment 69 Anti Tumor Activity 69 Treatment Experienced 69 Lowers Risk 69 Clostridium difficile Infection 69 Clinical Outcome 69 HCV Protease Inhibitor 69 Thrombus 69 Newly Diagnosed Patients 69 J Foot Ankle 69 Stenting 69 Antidepressants Linked 69 Bone Marrow Transplants 69 Clinical Efficacy 69 Infected Patients 69 Desvenlafaxine Succinate 69 Chemoradiation 69 Lung Cancer Patients 69 Boosts Survival 69 Coronary Artery 69 Drug Shows Promise 69 Phase 2a Clinical Trial 69 Mouse Model 69 Neovascular Age Related Macular 69 Multicenter Randomized 69 Prognostic Value 69 Balloon Angioplasty 69 Dose Escalation 69 Spinal Fusion 69 Cardiovascular Disease Risk 69 developing Bicifadine serotonin 69 Radical Prostatectomy 69 Skeletal Muscle 69 Osteoporosis Drugs 69 Advanced Pancreatic Cancer 69 Systemic Sclerosis 69 Seasonal Allergic Rhinitis 69 Initiates Clinical Trial 69 Hypercholesterolemia 69 Acute Coronary 68 Percutaneous Coronary Intervention 68 Controlled Study 68 Phospholipase A2 68 Diabetic Kidney Disease 68 Slows Progression 68 Renal Artery 68 Acute Decompensated Heart Failure 68 Non Invasive Treatment 68 II Clinical Trial 68 Adjuvant Treatment 68 Stress Incontinence 68 Atypical Hemolytic Uremic Syndrome 68 Drug Combo 68 Infarct 68 Breast Cancers 68 Laryngeal Cancer 68 Shows Promising 68 Hypertensive Patients 68 Anti Clotting Drug 68 Endovascular Repair 68 Gene Variant 68 Hyperuricemia 68 Phase IIb Clinical Trial 68 Gastric Cancer 68 Lymph Node 68 Treat Heart Failure 68 Levels Linked 68 Fewer Side Effects 68 Novel Oral 68 Bone Marrow Cells 68 Corneal Transplant 68 Clinically Significant 68 FDA Approves Drug 68 Hepatitis C Infection 68 Oral Calcitonin 68 Significant Reduction 68 Respiratory Distress 68 Treatment Naïve 68 Endometrial Cancer 68 Aggressive Prostate Cancer 68 Arterial Disease 68 Brain Atrophy 68 Randomized Phase III 68 Prostate Biopsy 68 Improves Quality 68 Sustained Efficacy 68 Stent Placement 68 Platelet Inhibition 68 Recurrent Breast Cancer 68 Estrogen Therapy 68 Autologous Stem Cell Transplantation 68 Completes Patient Enrollment 68 Regenerative Cells 68 Therapy Improves 68 MR Angiography 68 Liver Failure 68 Relapsed Refractory 68 Crit Care Med 68 Pre Cancerous 68 Malignant Melanoma 68 Study Demonstrates 68 Advanced Heart Failure 68 Novel Compounds 68 Chronic Renal Failure 68 Cognitive Impairment 68 Bronchopulmonary Dysplasia 68 Uterine Fibroid Embolization 68 Inflammatory Markers 68 Orthostatic Hypotension 68 Stem Cell Treatment 68 Tumor Growth 68 Lung Cancer Trial 68 An Opportunity Awaits 68 Reduces Risk 68 Lung Cancer Survival 68 complement inhibitor eculizumab 68 Reduces Pain 68 Aliskiren 68 bronchospasm dizziness headache 68 Malignant Glioma 68 Eur J 68 Enlarged Prostate 68 Teva Provides Update 68 Pivotal Clinical Trial 68 Hospitalized Patients 68 Improves Patient 68 Asthma Treatment 68 Investigational Agent 68 Guideline Update 68 Receives Orphan Drug Designation 68 Contrast Enhanced 68 Paroxysmal Nocturnal Hemoglobinuria PNH 68 Knee Arthritis 68 Myelofibrosis 68 Study Evaluates 68 Coronary Arteries 68 Combo Therapy 68 Improve Outcomes 68 Long Term Survival 68 Mylan Receives Approval 68 Beta Blocker 68 Improve Patient Outcomes 68 Critical Limb Ischemia 68 Significantly Reduces 68 Host Disease 68 Catheter Associated 68 J Cataract Refract 68 Mg Uk 68 Demonstrated Significant 68 Brain Lesions 68 Advanced Solid Tumors 68 Lowering Blood Pressure 68 Proves Effective 68 Valve Replacement 68 Lupus Drug 67 Monotherapy 67 Stent Thrombosis 67 Small Bowel 67 HER2 Positive 67 Peginterferon 67 Chronic Myeloid Leukemia 67 Tyrosine Kinase Inhibitor 67 Bare Metal Stent 67 Gene Variation 67 Ovarian Cancer Patients 67 Insulin Glargine 67 Migraine Headaches 67 Inflammatory Diseases 67 HER2 Positive Breast Cancer 67 Disease Progression 67 Oral Anticoagulant 67 Refractory Angina 67 Intravitreal 67 FDA Okays 67 Bone Fractures 67 Urinary Tract Infections 67 Double Blind Placebo 67 Thrombotic 67 Anticancer Activity 67 Kidney Failure 67 Demonstrate Significant 67 Randomized Clinical Trials 67 Cutaneous T 67 Hepatocellular Carcinoma 67 Treat Anemia 67 Drug Coated Stents 67 J Am Acad 67 Phase III Clinical Trial 67 Breathing Problems 67 Sleep Disordered Breathing 67 Dendritic Cells 67 Circulating Tumor Cells 67 Disease Modifying 67 Stent Implantation 67 Improve Patient Safety 67 intravesical infusion therapy 67 J Clin 67 Inflammatory Disease 67 Cardiac Arrest Patients 67 Stress Fractures 67 Often Misdiagnosed 67 Hormone Therapy 67 Intracerebral Hemorrhage 67 Drug Eluting Coronary Stent 67 unfractionated heparin UFH 67 Advanced Ovarian Cancer 67 Pivotal Trial 67 Shows Efficacy 67 Muscle Wasting 67 Prolongs Life 67 Proc Am Soc 67 Idiopathic Pulmonary Fibrosis 67 Colorectal Cancer Patients 67 Valvular 67 Invasive Breast Cancer 67 Novel Antibiotic 67 Patients Enrolled 67 Kidney Transplants 67 Nicotine Vaccine 67 Transplant Patients 67 Abdominal Fat 67 Panic Disorder 67 Progenitor Cells 67 First Patient Dosed 67 Recurrent Stroke 67 Investigational Compound 67 Chronic Liver Disease 67 Hepatitis C Genotype 67 Diabetic Nephropathy 67 MRSA Infections 67 Liver Tumors 67 Kidney Function 67 Neuroendocrine Tumors 67 Benign Prostatic Hyperplasia BPH 67 Bacterial Infections 67 Female Stress Urinary 67 Gastric Ulcers 67 NDA Submission 67 Coronary Artery Bypass Graft 67 Chronic Wounds 67 Brain Tumor Patients 67 Helps Predict 67 Ranolazine 67 Refractory Hodgkin Lymphoma 67 Venous Thrombosis 67 Phase 2b Study 67 Cardiogenic Shock 67 INTEGRILIN R 67 Carotid Artery 67 Lung Cancers 67 Follicular Lymphoma 67 Peripheral Arterial Disease 67 Magnetic Nanoparticles 67 Gastrointestinal Tract 67 Ischemia 67 vapreotide acetate 67 Randomized Controlled Trials 67 Oral Mucositis 67 Immune Responses 67 Aortic Stenosis 67 Premature Births 67 known dihydropyrimidine dehydrogenase 67 Cholesterol Lowering Drug 67 Mitral Valve Repair 67 Dialysis Patients 67 Allergic Rhinitis 67 Virus Infection 67 Radiation Induced 67 Hepatitis C Treatment 67 Significantly Improved 67 Breast Cancer Treatment 67 Pulmonary Vein Isolation 67 Arthritis Sufferers 67 Clot Busting 67 Electrical Stimulation 67 Microwave Ablation System 67 Statistically Significant 67 Meta Analysis 67 Circulatory Support 67 receiving VELCADE 67 Tissue Engineered 67 External Beam 67 Predict Risk 67 Valopicitabine 67 Phase III Pivotal 67 Expanded Indication 67 Antiplatelet 67 bone marrow reticulin deposition 67 Beta Blockers 67 FDA Clears 67 Esophageal 67 Phase III Trial 67 Antiplatelet Therapy 67 Intracranial 67 Multiple Myeloma Patients 67 Acute Renal Failure 67 migraine headaches AZ 67 Cervical Dysplasia 67 Randomized Double Blind 67 Treating Heart Failure 67 Intra Arterial 67 Respiratory Virus 67 Phase IIa Clinical Trial 67 Asthma Symptoms 67 Combination Therapy 67 Arch Facial Plast 67 Virus Linked 67 Increased Risk 67 Sapacitabine 67 Preterm Delivery 67 Limb Ischemia 67 Endothelial Dysfunction 67 Files IND 67 Obstructive Sleep Apnea 67 Hematology Molecular Pathology 67 Gene Linked 67 Blood Cancers 67 Paclitaxel Eluting 67 mild renal insufficiency 67 Brain Aneurysms 67 Blocked Arteries 67 Guidelines Recommend 67 Immune Cell 67 Hemorrhagic Stroke 67 Fondaparinux 67 Prognostic Factors 67 Bone Fracture 67 Controlled Trial 66 Carotid Artery Disease 66 Bipolar Mania 66 Liver Injury 66 Contrast Agents 66 Breast Density 66 undergoing elective percutaneous 66 Bleeding Disorder 66 Decompensated Heart Failure 66 RNAi Therapeutic 66 Aortic Valve 66 Drug Resistant 66 Heart Failure Treatment 66 Antibiotic Treatment 66 Prostate Cancer Vaccine 66 Bucindolol Based 66 BY STEVE KEMME 66 Announces FDA Clearance 66 Effectively Treats 66 Migraine Headache 66 Asthma COPD 66 Bevacizumab 66 Osteoporosis Treatment 66 Enhance Patient 66 Peginterferon Alfa 2a 66 Lung Function 66 Community Acquired Pneumonia 66 Deep Venous Thrombosis 66 Acute Coronary Syndrome 66 Endothelial Function 66 Varicose Veins 66 Obesity Linked 66 Kidney Transplant Recipients 66 Squamous Cell Carcinoma 66 Clostridium Difficile Associated 66 Stem Cell Procedure 66 Non Alcoholic Steatohepatitis 66 dual endothelin receptor antagonist 66 Vitamin D Linked 66 Clin J 66 included exfoliative dermatitis 66 FDA APPROVES 66 Nesiritide 66 Develop Novel 66 Prostate Cancer Recurrence 66 Preclinical Study 66 Chronic Constipation 66 Blood Vessel 66 Clinical Outcomes 66 Drug Candidate 66 Genes Linked 66 Hepatic Encephalopathy 66 Stenosis 66 Randomized Phase II 66 Lumbar Spine 66 Reduce Mortality 66 Prostate Tumors 66 Gout Drug 66 Mayo Clinic Study Finds 66 Gene Mutation 66 Telaprevir VX 66 Intravesical 66 ANN INTERN MED 66 Single Incision 66 Inhaled Steroids 66 Embolization 66 Physician Offices 66 Demonstrates Efficacy 66 Dose Ranging Study 66 Risk Stratification 66 Glaucoma Treatment 66 Demonstrates Significant 66 Being Studied 66 Sevelamer 66 Physical Function 66 Colorectal Adenomas 66 Hypotension 66 Investigational eFlow Nebulizer System 66 Chronic Cough 66 NPS Pharmaceuticals Announces 66 Blood Clot Risk 66 Placebo Controlled Study 66 Antibody Drug Conjugate 66 Bladder Cancer 66 Antifungals 66 Cardiac Biomarkers 66 Prognostic Significance 66 Pivotal Phase 66 Vaccine Adjuvant 66 Fibromyalgia Pain 66 Neovascularization 66 Platelet Counts 66 Gastroesophageal Reflux Disease 66 Oral Cladribine 66 Etanercept 66 Double Blind Randomized 66 Cardiovascular Prosthetic Devices 66 Acute Exacerbations 66 Non Responders 66 Bivalirudin 66 Clinical Evaluation 66 Initiates Enrollment 66 Newly Diagnosed 66 Showed Significant 66 Peripheral Artery Disease 66 Transplant Rejection 66 Transplant Patient 66 Anthrax Toxin 66 Thromboembolism 66 Osteoarthritis Pain 66 Topline Results 66 Solid Malignancies 66 Adult Stem Cell Therapy 66 Subarachnoid Hemorrhage 66 Breast Cancer Patients 66 Antipsychotic Drug 66 Node Positive 66 Epilepsy Drug 66 Respiratory Syncytial Virus 66 Significant Improvement 66 Pelvic Organ Prolapse 66 Percutaneous Tibial Nerve Stimulation 66 Glatiramer Acetate 66 Cholesterol Levels 66 Ischaemic 66 Orthop Surg 66 Diffuse Large B 66 Carbon Monoxide Poisoning 66 Genetic Variant 66 Study Compares 66 JAK2 Inhibitor 66 Diabetic Macular Edema 66 CABG Surgery 66 Blood Pressure Drug 66 acute PAO 66 Autoimmune Diseases 66 Focused Ultrasound 66 Insulin Resistance 66 Spinal Disc 66 Thrombolysis 66 Phase III Pivotal Trial 66 Intravenous Formulation 66 Clinical Trial Data 66 Kidney Stones 66 Cerebrospinal Fluid 66 Prevent Stroke 66 Improve Patient 66 Drug Eluting Stents 66 Hypertrophy 66 Tezampanel 66 Device Helps 66 Paroxysmal Nocturnal Hemoglobinuria 66 Viral Infections 66 Implantable Cardioverter Defibrillator 66 Int J Radiat Oncol 66 Autoimmune Disease 66 vascular occlusive diseases 66 Stable Coronary Artery 66 Excessive Sweating 66 Opioid Use 66 5 Fluorouracil 66 deep venous thromboses 66 Chronic Rhinosinusitis 66 Excellent oppty 66 Metastatic Pancreatic Cancer 66 Aneurysm Repair 66 Gum Disease 66 Certain Cancers 66 Nymox NX 66 TRANSDUR ™ 66 Surgical Treatment 66 Stent Restenosis 66 Presents Positive 66 CyberKnife Radiosurgery 66 INDUSTRY ASSESSMENTS 66 Carotid Endarterectomy 66 Reduced Risk 66 Anti CD# Antibody 66 Prostate Cancer Treatment 66 Who Underwent 66 Immunosuppression 66 Test Detects 66 Randomized Double blind 66 Transcatheter 66 Periodontal Disease 66 Anticoagulation 66 Intracoronary 66 Phase 1b Clinical Trial 65 infarction NSTEMI 65 Randomized Study 65 Progressive Multifocal Leukoencephalopathy 65 Trial Evaluating 65 Eculizumab 65 Thrombus Aspiration 65 Transdermal Patch 65 Pivotal Phase III 65 Vascular Ultrasound 65 Ovarian Cancers 65 Plus Ribavirin 65 Dementia Related Psychosis 65 CARDIOVASCULAR 65 Warfarin Coumadin 65 Juvenile Idiopathic Arthritis 65 Gastrointestinal Stromal Tumors 65 Unstable angina 65 Osteoporosis Drug 65 Foot Ankle 65 brand ciclesonide HFA 65 Adenoma 65 Total Hip Arthroplasty 65 Stomach Cancer 65 Valsartan 65 Patient Treated 65 Prostatectomy 65 Significantly Improves 65 Microdermabrasion Chemical Peels Collagen 65 Mouse Models 65 Acute Pain 65 Computed Tomographic 65 Phase Ib Clinical Trial 65 familial amyloidotic polyneuropathy FAP 65 Moxifloxacin 65 Thrombocytopenia 65 Induction Therapy 65 Female Urology 65 Granted Orphan Drug 65 Cardiol 65 Screening Mammography 65 Symptom Relief 65 Oral Cavity 65 Stem Cell Transplant 65 Thiazolidinediones 65 Molecular Diagnostic Test 65 Breast Tumors 65 Cardiac Arrhythmias 65 Angiographic 65 Muscle Function 65 Postoperative Pain 65 Acute Bacterial Sinusitis ABS 65 distal embolization thrombus formation 65 Mycophenolate Mofetil 65 Chronic Insomnia 65 CYPHER R Sirolimus Eluting 65 Balloon Kyphoplasty 65 Cardiac Rhythm 65 NICE Recommends 65 vitreoretinal disorders 65 Treatment Naïve Patients 65 Pressure Ulcers 65 Romiplostim 65 Blood Transfusions 65 Predict Prostate Cancer 65 Includes KCI proprietary 65 Initiate Phase III 65 Cardiotoxicity 65 Inflammatory Response 65 Tumor Response 65 Novel Method 65 Knee Implant 65 Gets FDA Clearance 65 CTAP# 65 Heart Circ Physiol 65 Protein Linked 65 Tiotropium 65 Cancer Recurrence 65 Relapsed Refractory Multiple Myeloma 65 PLX STROKE targeting 65 Herniated Disc 65 Recurrent Glioblastoma 65 Menopausal Symptoms 65 Telithromycin 65 Anticoagulant 65 Rectal Cancer 65 Surgical Technique 65 Vitrasert R 65 severe hepatomegaly 65 Randomized Phase 65 Potentially Fatal 65 Sentinel Lymph Node 65 Uterine Cancer 65 Schizophrenia Treatment 65 Stem Cell Transplants 65 Ebola Vaccine 65 Doctors Warn 65 Aeolus Pharmaceuticals Announces 65 Organ Rejection 65 Anthracycline 65 Ovary Removal 65 myocardial infarction hypersensitivity 65 pralatrexate injection folate analogue 65 reduce serum phosphate 65 Randomized Evaluation 65 Breast Carcinoma 65 Preterm Labor 65 NAVISTAR ® THERMOCOOL ® 65 LES EXPLOSIFS NORDEX LTEE 65 Central Retinal Vein 65 Blood Flow 65 Endothelial Cells 65 Carcinomas 65 Thromboembolic 65 Rotavirus Vaccine 65 Blood Vessels 65 Late Breaker 65 Stent Coating 65 Accelerated Partial Breast Irradiation 65 Robot Assisted 65 Hemodialysis Patients 65 Helps Identify 65 Radiation Dose 65 Viral Load 65 Endometrial Ablation 65 Peptic Ulcer 65 TRANSDUR ® 65 Irregular Heartbeat 65 Nephrol Dial Transplant 65 myelodysplastic myeloproliferative diseases 65 transurethral 65 Milestone Payment 65 Pivotal Study 65 Natalizumab 65 Nat Clin Pract 65 Hip Fracture 65 ACTEMRA TM 65 Obese Teens 65 Neurosurgical Products 65 TM Embolic Protection 65 Myelodysplastic Syndrome MDS 65 Evalve MitraClip R 65 Hepatobiliary 65 Vaccine Adjuvants 65 OR Live.com Presents 65 Left Atrial Appendage 65 Spectrum Pharmaceuticals Announces 65 Epidermal Growth Factor Receptor 65 Postherpetic Neuralgia 65 Balloon Catheters 65 Left Ventricular Dysfunction 65 Heart Failure Therapies 65 Depressive Symptoms 65 Left Ventricular Assist 65 Gene Variants 65 Ultrasound Guided 65 Percutaneous Transluminal Coronary Angioplasty 65 Allergic Reactions 65 Prostate Cancer Survival 65 Parenteral Nutrition 65 See WARNINGS 65 Placebo Controlled Trial 65 Own Stem Cells 65 Phase 2a Trial 65 Microalbuminuria 65 R famotidine 65 Renal Cancer 65 Cell Mol Physiol 65 Dilated Cardiomyopathy 65 Radioimmunotherapy 65 Pelvic Surgery 65 capillary leak 65 Anemia Drug 65 Combination REOLYSIN R 65 Migraine Pain 65 Lung Transplants 65 Angioedema 65 Microvascular 65 Dupuytren Disease 65 Initiate Clinical Trial 65 Antipsychotic Medications 65 #-# Full Text 65 Sandostatin R 65 Increases Risk 65 Severe Psoriasis 65 Long Term Outcomes 65 Cancer Treatments 65 R lenalidomide 65 Antipsychotic 65 Esophageal Cancer 65 Eases Pain 65 Bone Regeneration 65 Patency 65 Placebo Controlled 65 Stress Induced 65 Anticoagulants 65 Receives FDA Clearance 65 Skin Lesions 65 Adenomas 65 Commercialize Novel 65 Ribavirin causes 65 Pregnancy Linked 65 Rare Genetic 65 pulmonary alveolar 65 J Antimicrob Chemother 64 gastrointestinal GI motility disorders 64 Clinical Documentation 64 induce orthostatic hypotension 64 Iron Overload 64 Breast Biopsy 64 BCG refractory carcinoma 64 Rheumatoid 64 Previously Untreated Multiple Myeloma 64 Metabolic Disorder 64 Cognitive Function 64 Cell Transplant 64 Dyslipidemia 64 5q MDS 64 Medoxomil 64 Platinol ® 64 systemic lupus erythematosus psoriasis 64 Nephrol 64 Ventricular Tachycardia 64 Arch Neurol 64 Invasive Fungal Infections 64 Novel Mechanism 64 Colorectal Cancers 64 Cardiac Stem Cell 64 Resection 64 Therapeutic Efficacy 64 Confirmatory Phase 64 Genes Identified 64 Pulmonary Hypertension 64 Heart Transplantation 64 Cognitive Decline 64 Malignant Pleural Mesothelioma 64 Poorly Controlled 64 Epilepsy Drugs 64 includes Dideco CarboMedics 64 Antiviral Drugs 64 hyperphenylalaninemia HPA due 64 Wafer polifeprosan 64 Pegylated Liposomal Doxorubicin